Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIM23B065 in Acromegaly
NCT03045302Phase 2Terminated
- Sponsor
- Ipsen
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Peptides, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of BIM23B065 in acromegaly, sponsored by Ipsen. Started Jan 2017; status: terminated.
02
Drugs
BIM23B065
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT03045302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045302.